5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.42▼ | 1.42▼ | 1.41▼ | 1.49▼ | 1.63▼ |
MA10 | 1.41▼ | 1.42▼ | 1.44▼ | 1.57▼ | 1.63▼ |
MA20 | 1.51▼ | 1.51▼ | 1.53▼ | 1.68▼ | 1.58▼ |
MA50 | 1.62▼ | 1.62▼ | 1.63▼ | 1.72▼ | 2.82▼ |
MA100 | 1.71▼ | 1.83▼ | 1.98▼ | 1.59▼ | 7.07▼ |
MA200 | 2.07▼ | 1.92▼ | 1.92▼ | 2.24▼ | 32.70▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.007▼ | -0.008▼ | -0.010▼ | -0.041▼ | 0.117▲ |
RSI | 30.045▼ | 31.392▼ | 31.355▼ | 41.226▼ | 43.906▼ |
STOCH | 34.454 | 23.218 | 12.644▼ | 16.339▼ | 28.284 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -80.645▼ | -80.763▼ |
CCI | -96.642 | -98.246 | -96.507 | -141.485▼ | -64.185 |
Wednesday, May 15, 2024 10:37 PM
Q1 net Loss was $6.5 million for the three months ended March 31, 2024, compared to a net loss of $2.9 million for the three months ended March ...
|
Wednesday, May 15, 2024 10:54 AM
ADIL stock results show that Adial Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.More From InvestorPlace The #1 AI Investment Might Be This Company You’ve ...
|
Wednesday, May 15, 2024 01:29 AM
GLEN ALLEN, Va., May 15, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/05/24 | 1.37 | 1.49 | 1.30 | 1.42 | 212,520 |
14/05/24 | 1.41 | 1.47 | 1.365 | 1.44 | 120,255 |
13/05/24 | 1.47 | 1.47 | 1.445 | 1.445 | 250,980 |
10/05/24 | 1.63 | 1.6773 | 1.48 | 1.50 | 118,485 |
09/05/24 | 1.63 | 1.66 | 1.57 | 1.65 | 111,959 |
08/05/24 | 1.53 | 1.659 | 1.53 | 1.59 | 195,058 |
07/05/24 | 1.63 | 1.65 | 1.50 | 1.54 | 95,640 |
06/05/24 | 1.70 | 1.7471 | 1.60 | 1.63 | 224,299 |
03/05/24 | 1.80 | 1.8256 | 1.67 | 1.70 | 107,769 |
02/05/24 | 1.79 | 1.92 | 1.7634 | 1.79 | 245,297 |
|
|
||||
|
|
||||
|
|